| 2024-02-28 | +317.6% | news | Seeking Alpha | Vivani Medical surges after animal data on obesity implants |
| 2024-03-01 | -42.3% | news | Seeking Alpha | Vivani Medical announces pricing of $15M registered direct offering |
| 2023-05-02 | +34.8% | news | TradingView | VANI Stock Price and Chart — NASDAQ:VANI - TradingView |
| 2025-10-16 | +28.1% | news | Quiver Quantitative | Vivani Medical Stock (VANI) Opinions on Insider Purchase - Quiver Quantitative |
| 2025-10-16 | +28.1% | news | Investing.com | Vivani medical director Williams buys $1.98 million in VANI stock - Investing.com |
| 2022-12-15 | -26.4% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2021-06-04 | +24.9% | legal | SEC EDGAR | VANI 8-K: 8.01 (SEC Filing) |
| 2022-09-06 | -21.6% | earnings | MarketBeat | Vivani Medical (VANI) Stock Price, News & Analysis $VANI - MarketBeat |
| 2025-09-17 | +21.1% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2025-09-17 | +21.1% | news | MassDevice | Vivani sets date for neuromod spin-off as focus turns to drug delivery implant - MassDevice |
| 2021-06-03 | +21.0% | legal | SEC EDGAR | VANI 8-K: 8.01 (SEC Filing) |
| 2022-08-19 | -20.9% | legal | Seeking Alpha | Second Sight Medical sheds ~17% after reverse stock split |
| 2024-03-03 | -20.0% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2022-09-02 | -19.8% | legal | SEC EDGAR | VANI 8-K: 1.01, 2.01, 5.01, 5.02, 5.03, 7.01 (SEC Filing) |
| 2021-06-23 | -17.6% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2026-04-16 | +16.1% | legal | MT Newswires | Vivani Medical Insider Bought Shares Worth $1,999,999, According to a Recent SEC Filing |
| 2026-04-16 | +16.1% | news | Investing.com | Williams Gregg buys Vivani medical (VANI) shares worth $1.99m - Investing.com |
| 2026-04-16 | +16.1% | earnings | MarketBeat | Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,587,301 Shares - MarketBeat |
| 2026-04-16 | +16.1% | news | Cổng thông tin điện tử Tỉnh Sơn La | Vivani (VANI) Stock: Strengthening? (Parabolic) 2026-04-16 - Low Risk Entry - Cổng thông tin điện tử Tỉnh Sơn La |
| 2024-11-13 | +15.8% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.11 |
| 2024-11-13 | +15.8% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-05-15 | -14.9% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.12 |
| 2023-05-15 | -14.9% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-10-25 | +13.8% | news | Seeking Alpha | Vivani Medical director buys over 103k shares - filing |
| 2023-06-08 | -12.9% | news | Seeking Alpha | Cortigent, vision restoration device maker, sets terms for $15M IPO |
| 2023-06-13 | +11.8% | news | ChartMill | VANI Stock Price, Quote & Chart | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill |
| 2021-06-01 | -11.4% | legal | SEC EDGAR | VANI 8-K: 5.07, 8.01 (SEC Filing) |
| 2025-09-04 | +10.7% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2025-06-02 | -10.7% | news | Yahoo Finance | Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - Yahoo Finance |
| 2025-06-02 | -10.7% | news | Zacks Investment Research | Should I buy Vivani Medical, Inc. (VANI) - Zacks Investment Research |
| 2025-05-29 | +10.2% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2023-08-14 | -10.0% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.13 misses by $0.02 |
| 2024-03-05 | -10.0% | legal | SEC EDGAR | VANI 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-01-28 | +9.6% | news | Investing.com | Williams Gregg buys Vivani Medical (VANI) shares for $1.99m - Investing.com |
| 2026-02-17 | +9.5% | news | Quiver Quantitative | Insider Stock Purchases: February 17, 2026 - Quiver Quantitative |
| 2026-02-17 | +9.5% | news | Investing.com | Williams Gregg buys Vivani medical (VANI) shares worth $1.98 million - Investing.com |
| 2025-03-31 | -9.1% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.11 |
| 2025-03-31 | -9.1% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-14 | -9.0% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.13 |
| 2023-11-14 | -9.0% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-28 | +8.9% | legal | SEC EDGAR | VANI 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2025-10-28 | +8.9% | news | Investing.com | Williams Gregg buys Vivani medical shares worth $5.99m - Investing.com |
| 2025-10-28 | +8.9% | news | 24/7 Wall St. | Insiders Are Buying These 3 Stocks Hand Over Fist - 24/7 Wall St. |
| 2026-03-16 | +8.7% | legal | MT Newswires | Vivani Medical Insider Bought Shares Worth $1,683,335, According to a Recent SEC Filing |
| 2026-03-16 | +8.7% | news | Quiver Quantitative | Insider Stock Purchases: March 16, 2026 | VANI Stock News - Quiver Quantitative |
| 2026-03-16 | +8.7% | news | Investing.com | Vivani medical director Williams buys shares worth $1.68 million - Investing.com |
| 2026-03-16 | +8.7% | news | Insider Monkey | Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Ken Griffin, Cliff Asness, Davidson Kempner, L1 Capital, Palliser Capital, Boone Capital, Millennium Management, GigaCloud Technology Inc (GCT), Vivani Medical Inc (VANI), and More - Insider Monkey |
| 2025-10-03 | -8.2% | legal | SEC EDGAR | VANI 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-01-26 | -7.7% | news | Seeking Alpha | Vivani Medical prices common stock offering |
| 2026-01-27 | +7.6% | news | GlobeNewswire | Vivani Medical, Inc. Announces Closing of Common Stock Offering |
| 2026-01-27 | +7.6% | executive | 24/7 Wall St. | GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window |
| 2026-01-27 | +7.6% | legal | SEC EDGAR | VANI 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2026-01-27 | +7.6% | news | GlobeNewswire | Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewswire |
| 2026-01-27 | +7.6% | news | Investing.com | Vivani Medical closes $4.5 million stock offering to fund research - Investing.com |
| 2024-07-11 | +7.4% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2026-01-25 | -7.3% | news | Stock Titan | Vivani chair backs $4.5M raise for long-acting drug implants - Stock Titan |
| 2026-01-25 | -7.3% | news | Investing.com | Vivani Medical prices $4.5 million stock offering at $1.48 per share - Investing.com |
| 2026-01-25 | -7.3% | news | marketscreener.com | Vivani Medical announces pricing of common stock offering at $1.48 per share - marketscreener.com |
| 2026-04-01 | +7.2% | analyst | TipRanks | Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright |
| 2026-04-01 | +7.2% | earnings | MarketBeat | HC Wainwright Cuts Vivani Medical (NASDAQ:VANI) Price Target to $3.50 - MarketBeat |
| 2026-01-23 | -6.7% | news | simplywall.st | Vivani Medical, Inc. (NASDAQ:VANI) insiders have had a fantastic week as stock increased 17%, and they haven't stopped buying - simplywall.st |
| 2024-08-13 | +6.7% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.10 beats by $0.02 |
| 2024-08-13 | +6.7% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-11-11 | -6.5% | earnings | MarketBeat | Vivani Medical (VANI) Short Interest & Short Float | Updated Apr 2026 $VANI - MarketBeat |
| 2023-12-09 | -6.4% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Vivani Medical, Inc. (VANI) - Zacks Investment Research |
| 2026-03-26 | -6.3% | earnings | Associated Press Finance | Vivani Medical: Q4 Earnings Snapshot |
| 2026-03-26 | -6.3% | news | GlobeNewswire | Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
| 2026-03-26 | -6.3% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.43 misses by $0.01 |
| 2026-03-26 | -6.3% | legal | SEC EDGAR | VANI 8-K: 2.02 and (SEC Filing) |
| 2026-03-26 | -6.3% | earnings | Quiver Quantitative | VIVANI MEDICAL ($VANI) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative |
| 2026-03-26 | -6.3% | news | Stock Titan | Single semaglutide implant showed >20% weight loss for a year - Stock Titan |
| 2026-01-29 | -6.2% | news | GlobeNewswire | Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 |
| 2022-12-09 | -6.0% | analyst | marketscreener.com | Vivani Medical, Inc.: Target Price Consensus and Analysts Recommendations | VANI | US92854B1098 - marketscreener.com |
| 2025-03-26 | +6.0% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2023-08-29 | -5.9% | legal | SEC EDGAR | VANI 8-K: 1.01, 7.01 (SEC Filing) |
| 2022-11-14 | -5.9% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of $0.04 |
| 2022-11-14 | -5.9% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-31 | -5.8% | news | simplywall.st | Gregg Williams Bought 17% More Shares In Vivani Medical - simplywall.st |
| 2022-02-08 | +5.6% | legal | SEC EDGAR | VANI 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-11-13 | -5.5% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.11 in-line |
| 2025-11-13 | -5.5% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-31 | +5.3% | executive | 24/7 Wall St. | Insiders Are Still Scooping Up Under Armour and WR Berkley Shares |
| 2026-04-08 | -5.0% | news | Cổng thông tin điện tử tỉnh Lào Cai | Are investors bullish on Vivani (VANI) Stock | Price at $1.06, Down 4.50% - Trading Community - Cổng thông tin điện tử tỉnh Lào Cai |
| 2024-03-26 | -4.3% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.12 |
| 2024-03-26 | -4.3% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-03-06 | -4.3% | legal | SEC EDGAR | VANI 8-K: 5.02 and (SEC Filing) |
| 2024-03-06 | -4.3% | news | TradingView | Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant - TradingView |
| 2021-06-21 | -4.3% | legal | SEC EDGAR | VANI 8-K: 8.01 (SEC Filing) |
| 2025-03-13 | +4.1% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2024-09-26 | -4.1% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2021-06-28 | -3.9% | legal | SEC EDGAR | VANI 8-K: 1.01, 8.01 (SEC Filing) |
| 2022-11-28 | -3.8% | legal | SEC EDGAR | VANI 8-K: 1.01 and (SEC Filing) |
| 2024-04-22 | +3.8% | news | Seeking Alpha | Vivani Medical files for $300M mixed shelf |
| 2025-04-15 | +3.5% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2024-01-10 | -3.3% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2022-08-30 | -3.2% | M&A | Seeking Alpha | Second Sight, Nano Precision complete merger, renaming as Vivani Medical |
| 2022-08-30 | -3.2% | M&A | Business Wire | Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc. - Business Wire |
| 2024-09-23 | -3.0% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2025-12-05 | +2.9% | news | Yahoo Finance | Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently - Yahoo Finance |
| 2025-05-13 | -2.7% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.11 misses by $0.01 |
| 2025-05-13 | -2.7% | legal | SEC EDGAR | VANI 8-K: 1.01, 2.02, 3.02, 7.01, 8.01 (SEC Filing) |
| 2022-06-16 | +2.6% | legal | SEC EDGAR | VANI 8-K: 5.02 and (SEC Filing) |
| 2024-04-23 | +2.5% | legal | SEC EDGAR | VANI 8-K: 1.01 and (SEC Filing) |
| 2026-04-09 | -2.4% | news | Cổng thông tin điện tử tỉnh Lào Cai | What is the growth rate of Vivani (VANI) Stock | Price at $1.04, Down 1.89% - Index Investing - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-06-25 | +2.3% | legal | Stock Titan | VANI SEC Filings - Vivani Medical 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-03 | +2.3% | analyst | Zacks | Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock? |
| 2026-04-03 | +2.3% | analyst | Yahoo Finance | Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance |
| 2022-07-29 | -2.2% | M&A | Seeking Alpha | Second Sight stock rises as shareholders approve merger, name change, reverse stock split |
| 2022-07-29 | -2.2% | legal | SEC EDGAR | VANI 8-K: 5.07, 8.01 (SEC Filing) |
| 2024-06-13 | -2.1% | legal | Seeking Alpha | Vivani Medical gains as FDA lifts clinical hold on GLP-1 implant |
| 2024-06-13 | -2.1% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2025-03-12 | +1.8% | M&A | Seeking Alpha | Vivani Medical to divest its neurostimulation devices business |
| 2023-04-04 | -1.7% | news | Seeking Alpha | Vivani stock pops on final $1M NIH grant for artificial vision device study |
| 2025-10-27 | +1.6% | news | Seeking Alpha | Vivani Medical prices $16M offering at $1.62 per share |
| 2025-06-11 | +1.6% | executive | Seeking Alpha | Vivani Medical appoints Anthony Baldor as CFO |
| 2025-06-11 | +1.6% | legal | SEC EDGAR | VANI 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-03-27 | +1.4% | news | Seeking Alpha | Vivani Medical announces $8.25M private placement equity financing |
| 2025-03-27 | +1.4% | legal | SEC EDGAR | VANI 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2023-09-08 | +1.3% | news | Seeking Alpha | Vivani Medical Director William Gregg buys $50.2k worth of shares - filing |
| 2025-05-24 | -1.2% | news | Intellectia AI | VANI Forecast — Price Prediction for 2026. Should I Buy VANI? - Intellectia AI |
| 2026-04-23 | +1.1% | news | ChartMill | VANI Technical Analysis | Trend, Signals & Chart Patterns | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill |
| 2025-11-17 | +1.1% | news | Investing.com | Vivani medical director Williams buys $1.98 million in VANI stock - Investing.com |
| 2022-06-21 | +1.0% | legal | SEC EDGAR | VANI 8-K: 1.01 and (SEC Filing) |
| 2025-08-05 | -1.0% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01, 8.01 (SEC Filing) |
| 2023-03-21 | +0.8% | legal | SEC EDGAR | VANI 8-K: 1.01, 7.01 (SEC Filing) |
| 2023-07-10 | +0.7% | legal | SEC EDGAR | VANI 8-K: 3.03, 5.03, 8.01 (SEC Filing) |
| 2022-08-05 | -0.7% | legal | SEC EDGAR | VANI 8-K: 5.02 and (SEC Filing) |
| 2022-06-07 | -0.7% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2024-05-13 | +0.6% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.12 in-line |
| 2024-05-13 | +0.6% | legal | SEC EDGAR | VANI 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-07-18 | +0.5% | legal | Seeking Alpha | Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial |
| 2022-07-18 | +0.5% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2023-11-24 | -0.4% | legal | SEC EDGAR | VANI 8-K: 5.02 and (SEC Filing) |
| 2024-09-04 | -0.4% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2025-08-13 | -0.4% | earnings | Seeking Alpha | Vivani Medical GAAP EPS of -$0.12 misses by $0.02 |
| 2025-08-13 | -0.4% | legal | SEC EDGAR | VANI 8-K: 1.01, 2.02, 3.02, 7.01, 8.01 (SEC Filing) |
| 2022-10-17 | +0.3% | legal | SEC EDGAR | VANI 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-10-22 | +0.2% | legal | SEC EDGAR | VANI 8-K: 8.01 and (SEC Filing) |
| 2021-08-04 | -0.1% | legal | SEC EDGAR | VANI 8-K: 8.01 (SEC Filing) |